MedPath

Hyoscyamine

Generic Name
Hyoscyamine
Brand Names
Anaspaz, Donnatal, Ed Spaz, Hyophen, Levbid, Levsin, Nulev, Oscimin, Phenohytro, Phosphasal, Symax, Urelle, Uribel, Urimar Reformulated Oct 2013, Urin DS, Urogesic Blue Reformulated Apr 2012, Ustell, Utira
Drug Type
Small Molecule
Chemical Formula
C17H23NO3
CAS Number
101-31-5
Unique Ingredient Identifier
PX44XO846X

Overview

Hyoscyamine is a tropane alkaloid and the levo-isomer of atropine. It is commonly extracted from plants in the Solanaceae or nightshade family. Research into the action of hyoscyamine in published literature dates back to 1826. Hyoscyamine is used for a wide variety of treatments and therapeutics due to its antimuscarinic properties. Although hyoscyamine is marketed in the United States, it is not FDA approved.

Background

Hyoscyamine is a tropane alkaloid and the levo-isomer of atropine. It is commonly extracted from plants in the Solanaceae or nightshade family. Research into the action of hyoscyamine in published literature dates back to 1826. Hyoscyamine is used for a wide variety of treatments and therapeutics due to its antimuscarinic properties. Although hyoscyamine is marketed in the United States, it is not FDA approved.

Indication

As a drug that is not FDA approved, hyscyamine has no official indications. Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic. Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation. Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.

Associated Conditions

  • Biliary Colic
  • Colic
  • Cystitis
  • Diverticulitis
  • Heart Block
  • Irritable Bowel Syndrome (IBS)
  • Neurogenic Bladder
  • Neurogenic Bowel Dysfunction
  • Pancreatitis
  • Parkinsonism
  • Peptic Ulcer
  • Poisoning caused by anticholinesterases
  • Pylorospasm
  • Renal Colic
  • Spastic bladder
  • Tracheo-bronchial secretion excess
  • Acute Enterocolitis
  • Acute Rhinitis
  • Gastric secretions
  • Mild Dysentery
  • Pharyngeal secretions
  • Salivary secretions
  • Spastic colitis

FDA Approved Products

Hyoscyamine Sulfate
Manufacturer:Noble Pharmaceuticals, LLC
Route:ORAL
Strength:0.125 mg in 1 1
Approved: 2018/10/01
NDC:70156-105
Hyoscyamine ER
Manufacturer:Pharma Packaging Solutions, LLC dba Tjopack LLC
Route:ORAL
Strength:0.375 mg in 1 1
Approved: 2023/08/02
NDC:75929-057
Hyoscyamine Sulfate
Manufacturer:Vilvet Pharmaceuticals Inc
Route:ORAL
Strength:0.125 mg in 1 1
Approved: 2019/02/21
NDC:71186-008
Donnatal
Manufacturer:PBM Pharmaceuticals Inc.
Route:ORAL
Strength:0.1037 mg in 5 mL
Approved: 2013/12/03
NDC:66213-422
Hyoscyamine Sulfate SL
Manufacturer:RedPharm Drug, Inc.
Route:ORAL
Strength:0.125 mg in 1 1
Approved: 2020/01/20
NDC:67296-1280

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath